Nestlé plans to acquire nutritional health product maker Atrium Innovations Inc. for $2.3 billion. Plans call for Montreal-based Atrium, which is being purchased from a group of investors led by Permira Funds, to become part of Nestlé Health Science, Nestlé said Tuesday.
IRI has allied with Time Inc. subsidiary Viant to provide “people-based” target marketing and measurement for consumer packaged goods (CPG) and retail marketers.
Moberg Pharma AB is sharpening its focus on the North American marketplace as part of a reorganization of its sales and marketing operations. Moberg said it’s forming a global consumer health sales and marketing unit that includes both direct and distributor sales.
While the changes that CVS Health’s $69 billion deal to buy Aetna may bring to the health care sector remain unclear, it’s very likely that a big beneficiary of deal would be MinuteClinic, says one market researcher.
The Senate’s repeal of the Affordable Care Act (ACA) individual mandate as part of its sweeping tax reform bill has likely spelled doom for the provision, which required people who didn’t obtain health insurance to pay a tax penalty. Sen. John Barrasso (R., Wyo.
After a priority review of its supplemental Biologics License Application, Amgen has gained approval from the Food and Drug Administration for the cardiovascular drug Repatha.
The American Pharmacists Association (APhA) Foundation has partnered with The Kroger Co. and Solera Health for a program to help reduce the incidence of diabetes through community pharmacies.
Walgreens Boots Alliance (WBA) plans to pay about $416 million to acquire a 40% stake in Sinopharm Holding GuoDa Drug Store Co. WBA confirmed the deal on Monday. GuoDa is the largest retail pharmacy operator in China, with nearly 3,700 stores.
The Canadian government is stepping up efforts to rein in the cost of prescription drugs. At the start of this month, Canada proposed the first major update to the Patented Medicines Regulations in more than 20 years.
Following mounting speculation over the past month, CVS Health has unveiled a cash-and stock-deal to acquire health insurer Aetna Inc. for $69 billion. CVS and Aetna said Sunday evening that under the merger pact, Aetna shareholders will receive about $207 per share, including $145 in cash and 0.
Mylan N.V. has received Food and Drug Administration approval for Ogivri (trastuzumab-dkst), a biosimilar oncology drug co-developed with Biocon Ltd.
Speculation about a potential CVS Health acquisition of health insurer Aetna has been mounting over the past month, and now it may have reached a crescendo.
CVS Health has released findings from a poll on flu immunization as it urges families to get their shots during National Influenza Vaccination Week with the approach of peak flu season. A recent CVS survey found that 61% of Americans get a flu vaccine every year or plan to get one this
In January, Gillette plans to roll out eight men’s and women’s shaving and grooming solutions that the brand calls its “most comprehensive innovation bundle ever.
Lannett Co. has entered into an agreement with Aralez Pharmaceuticals Trading DAC, an Irish designated activity company, to become the exclusive U.S. distributor for metoprolol succinate extended-release tablets, a cardiovascular medication. Financial terms weren’t disclosed.
Jean Coutu Group shareholders have overwhelmingly approved the planned sale of the pharmacy chain to Quebec food and drug retailer Metro Inc. Jean Coutu said Wednesday that a near-unanimous 99.9% of votes cast sanctioned the $4.
